GUD:TSE
Knight Therapeutics Inc
CA$10.83
arrow_upward
+0.93%(+0.10) 1D
Oct 9, 4:00:00 PM GMT-4 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUD...
Open
CA$10.66
High
CA$11.00
Low
CA$10.40
Mkt. cap
1.06B
Avg. vol.
80.42K
Volume
76.84K
P/E ratio
72.21
52-wk high
CA$11.00
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
Open
CA$10.66
High
CA$11.00
Low
CA$10.40
Mkt. cap
1.06B
Avg. vol.
80.42K
Volume
76.84K
P/E ratio
72.21
52-wk high
CA$11.00
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
News stories
From web sources and news partners
Anadolu Ajansı
·
18 minutes ago
US stocks close mixed as higher oil prices, losses in chip stocks weigh on sentiment
CNBC
·
15 minutes ago
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
Chart Mill
·
1 hour ago
Discover the top S&P500 movers in Monday's after-hours session.
TradingView
·
2 hours ago
S&P 500 Dominated by AI Stocks, Adding SpaceX Would Create History Last Seen in 1880s
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersMontreal, Quebec, Canada
SectorPharmaceutical industry
Websiteknighttx.com